Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Sanofi ends development of Clostridium difficile vaccine

      Sanofi ends development of Clostridium difficile vaccine

      Ruby Khatun Khatun5 Dec 2017 9:45 AM IST
      Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection after an...
      Zydus gets tentative approval from USFDA for pregabalin

      Zydus gets tentative approval from USFDA for pregabalin

      Ruby Khatun Khatun4 Dec 2017 11:00 AM IST
      New Delhi: Zydus Pharmaceuticals (USA) Inc has received tentative approval from the US health regulator to market pregabalin capsules, used for...
      Jubilant Life Sciences gets Green panel nod for Rs 250 crore pesticide project

      Jubilant Life Sciences gets Green panel nod for Rs 250 crore pesticide project

      Ruby Khatun Khatun4 Dec 2017 10:55 AM IST
      New Delhi: The Centre's green panel has given the go-ahead to Jubilant Life Sciences Ltd (JLSL) for setting up a technical grade pesticide...
      Dr Reddy

      Dr Reddy's gets EIR for Hyderabad facility

      Ruby Khatun Khatun4 Dec 2017 10:45 AM IST
      New Delhi: Drug firm Dr. Reddy's Laboratories today said it has received establishment inspection report (EIR) from the US health regulator for its...
      Credihealth to raise around Rs 100 crore to fund expansion

      Credihealth to raise around Rs 100 crore to fund expansion

      Ruby Khatun Khatun4 Dec 2017 10:30 AM IST
      Medical assistance company Credihealth is looking to raise around Rs 100 crore to fund its expansion to up to 60 cities in the country by 2020, a top...
      Survey claims 59 percent people depend track medical symptoms on apps

      Survey claims 59 percent people depend track medical symptoms on apps

      Ruby Khatun Khatun4 Dec 2017 10:15 AM IST
      Mumbai: Healthcare apps are rapidly gaining popularity in the country with almost 59 percent of the people's usage increasing over the past year to...
      RxPrism launches CallWithDoctor for the healthcare industry

      RxPrism launches CallWithDoctor for the healthcare industry

      Ruby Khatun Khatun4 Dec 2017 10:00 AM IST
      BANGALORE: RxPrism Health Systems Pvt. Ltd. launches CallWithDoctor, a vibrant game-changing solution through which the company aspires to improve...
      Cuba battling medicine shortages in wake of cash crunch

      Cuba battling medicine shortages in wake of cash crunch

      Ruby Khatun Khatun4 Dec 2017 9:30 AM IST
      HAVANA: Cuba is working on fixing chronic medicine shortages that started appearing a year ago due to its cash crunch, health officials said in an...
      KKR seals 1.45 billion dollars for health deals: Report

      KKR seals 1.45 billion dollars for health deals: Report

      Ruby Khatun Khatun3 Dec 2017 12:30 PM IST
      New York: KKR & Co. closed on a $1.45 billion inaugural fund targeting growth-stage healthcare companies, solidifying yet another strategy for...
      Mylan and Biocon gets FDA approval for Ogivri to treat HER2-positive breast and gastric cancers

      Mylan and Biocon gets FDA approval for Ogivri to treat HER2-positive breast and gastric cancers

      Ruby Khatun Khatun3 Dec 2017 11:00 AM IST
      HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India: Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
      DRL receives FDA nod for anti-psoriasis cream

      DRL receives FDA nod for anti-psoriasis cream

      Ruby Khatun Khatun3 Dec 2017 10:45 AM IST
      Hyderabad: Dr. Reddy's Laboratories Ltd (DRL) said its US subsidiary Promius Pharma, LLC, received fifth consecutive and final approval for its...
      FDA clears first medical device accessory for Apple Watch

      FDA clears first medical device accessory for Apple Watch

      Ruby Khatun Khatun3 Dec 2017 10:30 AM IST
      The U.S. Food and Drug Administration (FDA) on Thursday cleared a device embedded in an Apple Inc watch band that monitors a user's heart rate,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok